Pentostatin Injection shortage
Current 1 presentations · 1 manufacturers · first FDA posting 2026-08-27 · last update 2026-10-08
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery: April 2027; Estimated Recovery: June 2027. Shortage per Manufacturer: Manufacturing Delay | Posted 08/27/2026 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)